Jinxing Wei
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Extracellular vesicles in disease
- Circular RNAs in diseases
- RNA modifications and cancer
Papers in
-
- Extracellular vesicles in disease 6
- Circular RNAs in diseases 4
-
- MicroRNA in disease regulation 10
- Cancer-related molecular mechanisms research 5
- Co-authors
- Min Jun (8 shared papers)Peiqing Liu (6 shared papers)Lihong Lv (6 shared papers)Qingfang Han (3 shared papers)Jun Cao (3 shared papers)Xuepei Zhang (5 shared papers)Changzhen Shang (5 shared papers)Haoming Lin (2 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (2 papers)Cell Death Discovery (1 paper)Journal of Endourology (1 paper)Cell Biology International (1 paper)Human Pathology (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Jinxing Wei
42 papers receiving 756 citations
Peers
Comparison fields: 5 of 90
- Cancer Research 351
- Molecular Biology 449
- Process Chemistry and Technology 16
- Molecular Medicine 26
- Catalysis 30
Countries citing papers authored by Jinxing Wei
This map shows the geographic impact of Jinxing Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinxing Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinxing Wei more than expected).
Fields of papers citing papers by Jinxing Wei
This network shows the impact of papers produced by Jinxing Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinxing Wei. The network helps show where Jinxing Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Jinxing Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 143 | |
| 2 | 2020 | 78 | |
| 3 | 2019 | 50 | |
| 4 | 2015 | 42 | |
| 5 | 2019 | 40 | |
| 6 | 2021 | 36 | |
| 7 | 2009 | 35 | |
| 8 | 2024 | 26 | |
| 9 | 2015 | 24 | |
| 10 | 2018 | 24 | |
| 11 | 2015 | 20 | |
| 12 | Prognostic role of PPAR-γ and PTEN in the renal cell carcinoma. | 2015 | 20 |
| 13 | Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma: report of a case and review of literature. | 2015 | 19 |
| 14 | 2019 | 18 | |
| 15 | 2023 | 18 | |
| 16 | 2014 | 15 | |
| 17 | Silencing MRP1-4 genes by RNA interference enhances sensitivity of human hepatoma cells to chemotherapy. | 2016 | 13 |
| 18 | 2019 | 12 | |
| 19 | 2022 | 11 | |
| 20 | 2020 | 10 |
About Jinxing Wei
Jinxing Wei is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Surgery and Oncology, having authored 43 papers that have together received 761 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (10 papers), Extracellular vesicles in disease (6 papers), Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (4 papers), Renal cell carcinoma treatment (4 papers), Ferroptosis and cancer prognosis (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Cancer Research (351 citations), Molecular Biology (449 citations), Process Chemistry and Technology (16 citations), Molecular Medicine (26 citations) and Catalysis (30 citations). Jinxing Wei has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Min Jun, Peiqing Liu, Lihong Lv, Qingfang Han, Jun Cao, Xuepei Zhang, Changzhen Shang, Haoming Lin, Guolin Li and Yanfeng Yang. Their work appears in journals such as Biomedicine & Pharmacotherapy, Cell Death Discovery, Journal of Endourology, Cell Biology International and Human Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.